Previous studies have demonstrated that larger tumor size, lymph node metastasis, higher nuclear grade, and positive HER2 status are typically poor prognostic indicators of breast cancer[45–48]. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.